LBX Pharmacy Chain Joint Stock Company Class A

LBX Pharmacy Chain Joint Stock Company Class A

SSSE:603883
14.91
CNY
+0.10
(+0.68%)
0.86EPS
20.88P/E
9.90BMarket Cap
Apr 23Next Earn
LBX Pharmacy Chain Joint Stock Company Class A
SSE:603883
(Shanghai Stock Exchange)

Recent

price

14.91

P/E

ratio

20.88

div

yld

3.62%

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
5.16
6.05
6.99
8.32
7.87
9.63
11.8
14.08
17.23
20.49
22.19
26.89
29.71
29.29
29.12
30.26
Revenue per Share
0.21
0.27
0.34
0.43
0.41
0.47
0.58
0.65
0.75
0.91
0.95
1.05
1.23
0.68
0.5
0.62
Basic EPS, GAAP
- -
0.18
0.14
0.27
0.19
0.17
0.3
0.06
0.9
1.55
2.57
2.67
2.79
1.99
3.78
- -
Free Cash Flow per Basic Share
0.01
0.06
0.03
0.11
0.01
0.14
0.2
0.5
0.34
0.26
0.24
0.4
0.5
0.94
0.29
0.54
Dividend per Share
1.14
1.37
1.71
1.53
3.51
2.93
4.35
4.52
5.14
6.05
6.31
8.59
8.81
8.66
8.61
8.8
Book Value per Share
0.82
1.06
0.83
0.75
2.12
0.71
1.66
1.06
1.07
1.37
0.28
0.58
0.16
-0.02
0.14
0.37
Tangible Book Value per Share
478
470
475
474
581
633
636
673
677
682
707
750
755
763
764
754
Basic Weighted Avg Shares
2,467
2,842
3,321
3,943
4,568
6,094
7,501
9,471
11,663
13,967
15,696
20,176
22,437
22,358
22,237
22,816
Sales/Revenue/Turnover
7.05
7.94
8.15
8.39
7.95
7.46
7.51
7.19
7.19
7.46
7.12
7.06
6.86
5.39
5.15
5.75
Operating Margin (%)
- -
24
25
33
39
47
54
72
95
112
1,100
1,195
1,334
1,473
1,439
- -
Depreciation Expense
99
125
161
202
241
297
371
435
509
621
669
785
929
519
382
471
Net Income, GAAP
27.99
25.27
23.51
23.5
22.43
19.14
19.51
20.79
20.17
20.11
18.22
19.16
20.19
25.2
28.53
30.44
Effective Tax Rate (%)
4.01
4.4
4.84
5.13
5.26
4.87
4.94
4.59
4.36
4.45
4.26
3.89
4.14
2.32
1.72
2.06
Profit Margin (%)
211
301
261
329
836
800
1,328
-635
-272
-1,745
-2,385
-1,383
-2,025
-1,846
-1,334
-1,481
Working Capital
- -
- -
- -
58
- -
792
888
84
649
2,711
3,500
3,400
2,750
2,920
2,640
1,989
LT Debt
607
733
916
1,086
2,292
1,945
3,101
3,369
3,875
4,680
4,779
7,098
7,289
7,156
6,996
7,138
Total Equity
- -
16.64
16.95
16.7
13.67
11.47
10.48
10.62
11.15
10.01
7.66
8.25
8.85
5.34
4.28
5.49
Return on Invested Capital (%)
- -
12
12.74
13.69
10.94
9.68
10.39
8.72
8.31
6.93
7.01
6.69
7.1
3.85
2.58
2.57
Return on Capital (%)
- -
21.07
22.03
22.77
15.1
14.59
15.51
14.56
15.57
16.2
15.68
14.42
14.04
7.82
5.82
7.02
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
1,876
1,658
1,776
LT Borrowings
1,316
1,152
935
LT Finance Leases
1,199
1,135
1,054
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
759
759
759
Market Capitalization
10,268
8,317
9,896

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
9,018
8,309
8,453
Cash, Cash Equivalents & STI
2,669
2,318
2,092
Accounts Receivable, Net
1,988
1,755
1,741
Inventories
3,634
3,475
3,882
Total Current Liabilities
10,050
9,206
9,934
Payables & Accruals
- -
- -
- -
ST Debt
1,876
1,658
1,776
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
13.8%
9.86%
-2.23%
Free Cash Flow
165.23%
30.08%
90.21%
Net Income, GAAP
7.75%
-5.44%
-26.44%
Sales/Revenue/Turnover
17.69%
10.25%
-0.54%
Total Cash Common Dividend
184.77%
24.14%
-68.54%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
5,539
5,401
5,292
6,125
22,358
2025
5,435
5,339
- -
6,166
22,237
2026
5,481
5,516
5,653
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.42
0.24
0.17
-0.15
0.68
2025
0.33
0.19
- -
-0.19
0.5
2026
0.35
0.24
0.23
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.29
0.26
0.39
0.94
2025
0.01
0.03
- -
0.2
0.29
2026
0.01
0.02
0.31
- -
- -
Business
LBX Pharmacy Chain Joint Stock Company (603883.SS) operates one of China's largest pharmacy retail chains, primarily engaged in the retail and wholesale of pharmaceuticals and health products through an extensive network of stores across mainland China. The company offers proprietary Chinese and Western medicines, traditional Chinese medicine tablets and decoctions, health equipment, health foods, general foods, personal care products, daily necessities, over-the-counter medications, and maternal and infant products; it also provides e-commerce services, Chinese medicine research and development, clinic and medical services, pharmaceutical consulting, information technology consulting, and wholesale distribution to pharmacies, hospitals, and healthcare providers. Operating through retail, wholesale, and other segments including pharmaceutical manufacturing, LBX Pharmacy Chain serves consumers and institutions in 21 provincial markets with over 15,000 stores and approximately 40,000 employees. Founded in 2001 by Zilong Xie and headquartered in Changsha, Hunan province, the company, formerly known as Laobaixing Pharmacy Chain Joint Stock Company, maintains a strong presence in regions including Hunan, Jiangsu, and others while focusing on chronic disease management for conditions such as breast cancer, skin diseases, leukemia, lung cancer, and hemophilia. Recent developments include the completion of acquisitions for stakes in regional pharmacy chains, such as the remaining 35% in Zhenjiang Huakang Pharmacy Chain Co., Ltd. and a 35% stake in Yangzhou Baixinyuan Pharmaceutical Chain Co., Ltd. for CNY210 million, alongside ongoing initiatives like the Torch Project to innovate commercial procurement and enhance profitability, store transformations from transaction-based to relationship-oriented models, and recognitions including a repeat listing in the 2025 China Services Enterprise 500.